Literature DB >> 20047119

Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.

Hiromitsu Hayashi1, Toru Beppu, Kazutoshi Okabe, Toshiro Masuda, Hirohisa Okabe, Takatoshi Ishiko, Hideo Baba.   

Abstract

PURPOSE: Infarcted splenic volume has been identified as the predictive factor for a prolonged increase in platelet count after partial splenic embolization (PSE). However, despite enough infarcted splenic volume, some patients show only a slight increase in platelet counts after PSE because of rapid regrowth of the noninfarcted splenic parenchyma within several months post-PSE. The purpose of this study was to determine the therapeutic factors based on the preoperative splenic volume for a prolonged increase in platelet counts after PSE.
METHODS: In 72 cirrhotic patients with follow-ups longer than 1 year post-PSE, depending on the preoperative splenic volume, the splenic factors associated with a prolonged increase in platelet counts at 1 year after PSE were retrospectively examined.
RESULTS: In 57 patients with preoperative splenic volumes <or=700 ml, the preoperative splenic volume (P = 0.001), infarcted splenic volume (P < 0.001), and splenic infarction ratio (P = 0.001) showed positive correlations with increments in platelet counts at 1 year post-PSE. In 15 patients with preoperative splenic volumes >700 ml, noninfarcted splenic volume (P = 0.003) and splenic infarction ratio (P = 0.002) showed negative and positive correlations with the increment in platelet counts at 1 year post-PSE, respectively.
CONCLUSIONS: In patients with splenic volumes <or=700 ml, the infarcted splenic area significantly affects the prolonged increase in platelet counts post-PSE. In patients with splenic volumes >700 ml, the noninfarcted splenic area is significant.

Entities:  

Mesh:

Year:  2010        PMID: 20047119     DOI: 10.1007/s00535-009-0185-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.

Authors:  Hiromitsu Hayashi; Toru Beppu; Toshiro Masuda; Takao Mizumoto; Masashi Takahashi; Takatoshi Ishiko; Hiroshi Takamori; Keiichiro Kanemitsu; Masahiko Hirota; Hideo Baba
Journal:  J Gastroenterol Hepatol       Date:  2007-08-07       Impact factor: 4.029

2.  Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.

Authors:  José R Foruny; Javier Blázquez; Ana Moreno; Rafael Bárcena; Luis Gil-Grande; Carmen Quereda; María J Pérez-Elías; Javier Moreno; Juan Sánchez; Alfonso Muriel; Miguel A Rodriguez-Sagrado; Santiago Moreno
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 2.566

3.  Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.

Authors:  H Noguchi; K Hirai; Y Aoki; K Sakata; K Tanikawa
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

4.  Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.

Authors:  Gisèle N'Kontchou; Olivier Seror; Valérie Bourcier; Djamila Mohand; Yves Ajavon; Laurent Castera; Véronique Grando-Lemaire; Nathalie Ganne-Carrie; Nicolas Sellier; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-02       Impact factor: 2.566

5.  Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis.

Authors:  Takashi Tajiri; Masahiko Onda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Tatsuo Kumazaki
Journal:  Hepatogastroenterology       Date:  2002 Sep-Oct

6.  Partial splenic embolization, an alternative to splenectomy--results of a prospective, randomized study.

Authors:  M F Mozes; D G Spigos; R Pollak; R Abejo; D G Pavel; W S Tan; O Jonasson
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

7.  Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Authors:  John G McHutchison; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Mark Sulkowski; Robert Kauffman; Lindsay McNair; John Alam; Andrew J Muir
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

8.  Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

Authors:  Christophe Hézode; Nicole Forestier; Geoffrey Dusheiko; Peter Ferenci; Stanislas Pol; Tobias Goeser; Jean-Pierre Bronowicki; Marc Bourlière; Shahin Gharakhanian; Leif Bengtsson; Lindsay McNair; Shelley George; Tara Kieffer; Ann Kwong; Robert S Kauffman; John Alam; Jean-Michel Pawlotsky; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

9.  Partial splenic embolization.

Authors:  Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Takashi Tajiri
Journal:  Hepatol Res       Date:  2007-11-23       Impact factor: 4.288

10.  Risk factors for complications after partial splenic embolization for liver cirrhosis.

Authors:  H Hayashi; T Beppu; K Okabe; T Masuda; H Okabe; H Baba
Journal:  Br J Surg       Date:  2008-06       Impact factor: 6.939

View more
  9 in total

1.  Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients.

Authors:  Daisuke Yoshida; Yoshihiro Nagao; Morimasa Tomikawa; Hirofumi Kawanaka; Tomohiko Akahoshi; Nao Kinjo; Hideo Uehara; Naotaka Hashimoto; Makoto Hashizume; Yoshihiko Maehara
Journal:  Hepatol Int       Date:  2011-09-30       Impact factor: 6.047

Review 2.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-09-18

3.  Combined measurements of serum bile acid level and splenic volume may be useful to noninvasively assess portal venous pressure.

Authors:  Hiromitsu Hayashi; Toru Beppu; Hirohisa Okabe; Hidetoshi Nitta; Katsunori Imai; Koichi Doi; Akira Chikamoto; Hideo Baba
Journal:  J Gastroenterol       Date:  2012-05-09       Impact factor: 7.527

4.  Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.

Authors:  Mingyue Cai; Wensou Huang; Chaoshuang Lin; Zhengran Li; Jiesheng Qian; Mingsheng Huang; Zhaolin Zeng; Jingjun Huang; Hong Shan; Kangshun Zhu
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

5.  Total and viable residual splenic volume measurement after partial splenic embolization by three-dimensional ultrasound.

Authors:  Hisashi Hidaka; Guoqin Wang; Takahide Nakazawa; Mitsuhiro Kida; Michiko Yanagihara; Shigeru Fujii; Akitaka Shibuya; Wasaburo Koizumi
Journal:  J Med Ultrason (2001)       Date:  2013-04-09       Impact factor: 1.314

Review 6.  Ultrasonography in the diagnosis of complications in patients with portal hypertension.

Authors:  Hisashi Hidaka; Haruki Uojima
Journal:  J Med Ultrason (2001)       Date:  2021-11-17       Impact factor: 1.878

7.  Repeated partial splenic artery embolization for hypersplenism improves platelet count.

Authors:  Youwen Tan; Jiamin Wang; Li Sun; Yun Ye
Journal:  Open Med (Wars)       Date:  2022-04-25

Review 8.  Management of thrombocytopenia due to liver cirrhosis: a review.

Authors:  Hiromitsu Hayashi; Toru Beppu; Ken Shirabe; Yoshihiko Maehara; Hideo Baba
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 9.  Management of thrombocytopenia in advanced liver disease.

Authors:  V G R Gangireddy; P C Kanneganti; S Sridhar; S Talla; T Coleman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.